Defyrus Inc.
Vaccine patent portfolio licensed from UK Ministry of Defence
Published in TB and Outbreaks Week, March 3rd, 2009
Defyrus Inc. announced the signing an exclusive, worldwide license to a patent portfolio created by the United Kingdom's Defence Science and Technology Laboratory (Dstl) and licensed by Ploughshare Innovation Ltd, Dstl's commercialization company. These patents form the intellectual property foundation of the Company's vaccine product development programs. Defyrus and Ploughshare Innovation Ltd plan to expand their commercial interaction in 2009 to include preclinical safety and efficacy studies as part of the Company's vaccine development program. The commercial terms of the license were not disclosed.
The licensed technology of 27 issued & pending international...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Lifespan
Study calls for increased research in flu transmission to prepare for pandemic flu outbreak - Aneurysm
Study results from T. Watanabe and colleagues broaden understanding of aneurysm - Arenavirus
Study data from G.C. Bowick and colleagues update understanding of arenavirus - Aspergillosis
Data from University of California advance knowledge in aspergillosis - Aspergillosis
New aspergillosis study results reported from University of Nebraska - Aspergillosis
New findings from University of Texas in the area of aspergillosis described - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
